Hexoskin's CEO Pierre-Alexandre Fournier is going to present our latest work in AI and digital biomarker development for clinical trials at the HITLAB Innovators Summit 2025 this December 2-4 in New York City.
This is going to be the first conference Hexoskin is participating in since it received FDA 510(k) clearance for the Hexoskin Medical System, a long-term ECG and respiratory wearable device and software system.

Hexoskin has been involved in clinical research for over 10 years, including work with NASA, Columbia, Harvard, Yale, McGill, Mayo Clinic, and many of the 20 largest pharmaceutical companies in the world.
HITLAB is dedicated to health technology companies and healthcare organizations improving the quality of health delivery worldwide. They use rigorous research and evidence-based methods to identify the best digital health solutions for each of their partners.
You can use discount code SUMMITPAF20 to get a 20% discount the event tickets.